| Affiliation: | 1. Diabetes and Endocrine Platform Team, Eli Lilly and Company, Indianapolis, Indiana;2. Section of Endocrinology, Diabetes, and Metabolism, Dartmouth Medical School and Dartmouth-Hitchcock Medical Center, Hanover, New Hampshire;3. Department of Clinical Sciences, Warwick Medical School, Warwick, United Kingdom;4. School of Medicine, Division of Endocrinology, Metabolism, and Diabetes, University of Miami, Miami, Florida;5. Illawarra Diabetes Service, Sydney, Australia;6. Papageorgiou Hospital, Thessaloniki, Greece;2. The IOOI Study Investigators are listed in the Acknowledgments.;1. Warwick Medical School, Clinical Science Research Institute, Clinical Science Building, University Hospital -- Walsgrave Campus, Clifford Bridge Road, Coventry CV2 2DX, UK;2. Institute of Obesity, Nutrition and Exercise, University of Sydney, Camperdown, NSW 2006, Australia;3. The University of Rochester, 601 Elmwood Ave, Box MED/CRC, Rochester, NY 14642, USA;4. University of Helsinki, Diabetes and Genetic Epidemiology Unit, Department of Epidemiology and Health Promotion, National Public Health Institute, Mannerheimintie 166, Helsinki FIN-00300, Finland |
